Company: RPTX
Filing Date: 2025-08-08
Form Type: 10-Q
Source: 0000950170-25-105468
Chunk: 8

Company: Repare Therapeutics Inc.
Filing Date: 2025-08-08
Form: 10-Q
Item: Item 6
Chunk 8
---
Incorporated by Reference

     ExhibitNumber
      
     Description
      
     ScheduleForm
      
     FileNumber
      
     Exhibit
      
     Filing Date

     3.1
      
     Articles of Continuance of Repare Therapeutics Inc.
      
     8-K
      
     001-39335
      
     3.1
      
     June 23, 2020

     3.2
      
     Amended and Restated Bylaws of Repare Therapeutics Inc.
      
     8-K
      
     001-39335
      
     3.2
      
     June 23, 2020

     10.1*+
      
     Employment Agreement between the registrant and Sandra Alves, dated May 28, 2025.

     10.2*† 
      
     Sixth Amendment to Collaboration and License Agreement by and between the registrant, Repare Therapeutics USA Inc. and Bristol-Myers Squibb Company, dated June 13, 2025. 

     31.1*
      
     Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

     32.1**
      
     Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     101.INS*
      
     Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document

     101.SCH*
      
     Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

     104
      
     Inline Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* Filed herewith.

** This certification is being furnished solely to accompany this Quarterly Report on Form 10-Q pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to